These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies? Fein A; Wiener-Kronish JP; Niederman M; Matthay MA Crit Care Clin; 1986 Jul; 2(3):429-53. PubMed ID: 3331557 [TBL] [Abstract][Full Text] [Related]
3. Depression of serotonin uptake by rat lungs exposed to paraquat. Block ER; Schoen FJ J Pharmacol Exp Ther; 1982 Apr; 221(1):254-60. PubMed ID: 7062288 [TBL] [Abstract][Full Text] [Related]
5. Early metabolic changes in response to lung injury: extrapolation from animals to humans. Block ER J Toxicol Environ Health; 1984; 13(2-3):369-86. PubMed ID: 6376818 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary endothelial cell injury and altered lung metabolic function. Early detection of the adult respiratory distress syndrome and possible functional significance. Wiedemann HP; Matthay MA; Gillis CN Clin Chest Med; 1990 Dec; 11(4):723-36. PubMed ID: 2268998 [TBL] [Abstract][Full Text] [Related]
7. Depressed prostaglandin E1 and 5-hydroxytryptamine removal in patients with adult respiratory distress syndrome. Gillis CN; Pitt BR; Wiedemann HP; Hammond GL Am Rev Respir Dis; 1986 Oct; 134(4):739-44. PubMed ID: 3532886 [TBL] [Abstract][Full Text] [Related]
8. Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation. Cook DR; Brandom BW Anesth Analg; 1982 Aug; 61(8):671-5. PubMed ID: 7201270 [TBL] [Abstract][Full Text] [Related]
9. Altered metabolic function of the pulmonary microcirculation. Early detection of lung injury and possible functional significance. Wiedemann HP; Gillis CN Crit Care Clin; 1986 Jul; 2(3):497-509. PubMed ID: 3331559 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary sequelae and lung repair in survivors of the adult respiratory distress syndrome. Ingbar DH; Matthay RA Crit Care Clin; 1986 Jul; 2(3):629-65. PubMed ID: 3331567 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary disposition and effects of drugs on pulmonary removal of endogenous substances. Mehendale HM Fed Proc; 1984 Aug; 43(11):2586-91. PubMed ID: 6204891 [TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary metabolic function can serve as a monitor for lung preservation. Hammond GL; Pitt B; Gillis CN J Heart Transplant; 1986; 5(1):23-8. PubMed ID: 3612350 [TBL] [Abstract][Full Text] [Related]
14. Respiratory and non-respiratory lung function indices during the development and resolution of O,S,S-trimethyl phosphorodithioate-induced lung damage in the rat. A chemical model of adult respiratory distress syndrome. Nemery B J Appl Toxicol; 1987 Dec; 7(6):391-6. PubMed ID: 3429765 [TBL] [Abstract][Full Text] [Related]
15. Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review). Cziráki A; Horváth IG; Papp L Int J Mol Med; 2002 Mar; 9(3):317-25. PubMed ID: 11836639 [TBL] [Abstract][Full Text] [Related]
16. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. van der Heijden M; Verheij J; van Nieuw Amerongen GP; Groeneveld AB Crit Care Med; 2009 Apr; 37(4):1275-81. PubMed ID: 19242338 [TBL] [Abstract][Full Text] [Related]
17. Respiratory infections and acute lung injury in systemic illness. Skerrett SJ; Niederman MS; Fein AM Clin Chest Med; 1989 Dec; 10(4):469-502. PubMed ID: 2689063 [TBL] [Abstract][Full Text] [Related]